WO2001095874A2 - Highly efficient delivery of a large therapeutic mass aerosol - Google Patents

Highly efficient delivery of a large therapeutic mass aerosol Download PDF

Info

Publication number
WO2001095874A2
WO2001095874A2 PCT/US2001/018491 US0118491W WO0195874A2 WO 2001095874 A2 WO2001095874 A2 WO 2001095874A2 US 0118491 W US0118491 W US 0118491W WO 0195874 A2 WO0195874 A2 WO 0195874A2
Authority
WO
WIPO (PCT)
Prior art keywords
agent
particles
composition
respirable
respirable composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/018491
Other languages
English (en)
French (fr)
Other versions
WO2001095874A3 (en
Inventor
David A. Edwards
Richard P. Batycky
Lloyd Johnston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Inhalation Research Inc
Original Assignee
Advanced Inhalation Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24365965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2001095874(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to AU2001275368A priority Critical patent/AU2001275368B2/en
Priority to NZ523254A priority patent/NZ523254A/en
Priority to DK01942072T priority patent/DK1296663T3/da
Priority to SI200130734T priority patent/SI1296663T1/sl
Priority to EP01942072A priority patent/EP1296663B1/en
Priority to AU7536801A priority patent/AU7536801A/xx
Priority to HK03103294.4A priority patent/HK1051139B/en
Priority to IL15328101A priority patent/IL153281A0/xx
Application filed by Advanced Inhalation Research Inc filed Critical Advanced Inhalation Research Inc
Priority to DE60127407T priority patent/DE60127407T2/de
Priority to PL36028701A priority patent/PL360287A1/xx
Priority to JP2002510053A priority patent/JP2004503482A/ja
Priority to KR1020027016748A priority patent/KR100697479B1/ko
Priority to MXPA02012023A priority patent/MXPA02012023A/es
Priority to CA002412561A priority patent/CA2412561C/en
Publication of WO2001095874A2 publication Critical patent/WO2001095874A2/en
Priority to NO20025873A priority patent/NO20025873L/no
Anticipated expiration legal-status Critical
Publication of WO2001095874A3 publication Critical patent/WO2001095874A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PCT/US2001/018491 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol Ceased WO2001095874A2 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CA002412561A CA2412561C (en) 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol
NZ523254A NZ523254A (en) 2000-06-09 2001-06-08 Method of delivering a large therapeutic mass aerosol to the pulmonary system
DK01942072T DK1296663T3 (da) 2000-06-09 2001-06-08 Meget effektiv tilförsel af en aerosol med stor terapeutisk masse
SI200130734T SI1296663T1 (sl) 2000-06-09 2001-06-08 Visoko uäśinkovito razdeljevanje velike terapevtske mase aerosola
EP01942072A EP1296663B1 (en) 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol
AU7536801A AU7536801A (en) 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol
HK03103294.4A HK1051139B (en) 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol
IL15328101A IL153281A0 (en) 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol
DE60127407T DE60127407T2 (de) 2000-06-09 2001-06-08 Hochwirksame verabreichung eines aerosols mit hoher therapeutischer masse
AU2001275368A AU2001275368B2 (en) 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol
KR1020027016748A KR100697479B1 (ko) 2000-06-09 2001-06-08 많은 치료학적 양의 에어로졸을 효과적으로 전달하는 방법
JP2002510053A JP2004503482A (ja) 2000-06-09 2001-06-08 大治療質量エアロゾルの高度に効率的な送達
PL36028701A PL360287A1 (en) 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol
MXPA02012023A MXPA02012023A (es) 2000-06-09 2001-06-08 Administracion altamente eficiente de un aerosol de masa terapeutica grande.
NO20025873A NO20025873L (no) 2000-06-09 2002-12-06 Meget effektiv levering av en stor terapeutisk mengde aerosol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/591,307 US6858199B1 (en) 2000-06-09 2000-06-09 High efficient delivery of a large therapeutic mass aerosol
US09/591,307 2000-06-09

Publications (2)

Publication Number Publication Date
WO2001095874A2 true WO2001095874A2 (en) 2001-12-20
WO2001095874A3 WO2001095874A3 (en) 2003-01-16

Family

ID=24365965

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/018491 Ceased WO2001095874A2 (en) 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol

Country Status (20)

Country Link
US (6) US6858199B1 (https=)
EP (2) EP1767196A3 (https=)
JP (2) JP2004503482A (https=)
KR (1) KR100697479B1 (https=)
CN (1) CN100589796C (https=)
AT (1) ATE357222T1 (https=)
AU (2) AU7536801A (https=)
CA (1) CA2412561C (https=)
DE (1) DE60127407T2 (https=)
DK (1) DK1296663T3 (https=)
ES (1) ES2283417T3 (https=)
IL (1) IL153281A0 (https=)
MX (1) MXPA02012023A (https=)
NO (1) NO20025873L (https=)
NZ (1) NZ523254A (https=)
PL (1) PL360287A1 (https=)
PT (1) PT1296663E (https=)
RU (1) RU2275900C2 (https=)
SI (1) SI1296663T1 (https=)
WO (1) WO2001095874A2 (https=)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024158A3 (en) * 2000-09-19 2002-09-19 Advanced Inhalation Res Inc Pulmonary delivery in treating disorders of the central nervous system
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
WO2003079992A2 (en) 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Pulmonary delivery for levodopa
WO2006033604A1 (en) * 2004-09-24 2006-03-30 Mederio Ag A metered medication dose
JP2006523632A (ja) * 2003-04-16 2006-10-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 放射標識された微粒子、その製造方法及びその使用
AU2002316574B2 (en) * 2002-03-15 2008-05-01 Brandeis University Central airway administration for systemic delivery of therapeutics
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
EA016072B1 (ru) * 2005-05-18 2012-01-30 Палметрикс Инк. Применение состава соли кальция для изменения биофизических свойств слизистой оболочки
US8758824B2 (en) 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
US8887715B2 (en) 2003-06-13 2014-11-18 Civitas Therapeutics, Inc. Low dose pharmaceutical powders for inhalation
EP2893921A1 (en) * 2002-03-20 2015-07-15 Civitas Therapeutics, Inc. Method and apparatus for producing dry particles
US9119778B2 (en) 2009-03-26 2015-09-01 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
US9387169B2 (en) 2014-11-07 2016-07-12 Civitas Therapeutics, Inc. Rapamycin powders for pulmonary delivery
US9539211B2 (en) 2012-11-09 2017-01-10 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US9585834B2 (en) 2004-11-23 2017-03-07 Vectura Limited Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives
US9642798B2 (en) 2010-09-29 2017-05-09 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
EP1531794B1 (en) * 2002-06-28 2017-05-10 Civitas Therapeutics, Inc. Inhalable epinephrine
US9737518B2 (en) 2013-04-01 2017-08-22 Pulmatrix Operating Company, Inc. Tiotropium dry powders
US9744130B2 (en) 2010-09-29 2017-08-29 Pulmatrix Operating Company, Inc. Cationic dry powders
US10589039B2 (en) 2012-02-29 2020-03-17 Pulmatric Operating Company, Inc. Methods for producing respirable dry powders

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6749835B1 (en) * 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2002032396A2 (en) * 2000-10-16 2002-04-25 Massachusetts Institute Of Technology Lipid-protein-sugar particles for delivery of nucleic acids
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
EP1487411B1 (en) 2002-03-20 2019-01-02 Civitas Therapeutics, Inc. Inhalable sustained therapeutic formulations
US6923175B2 (en) 2002-03-20 2005-08-02 Mannkind Corporation Inhalation apparatus
US6930137B2 (en) * 2002-05-31 2005-08-16 Fina Technology, Inc. Method of improving blown film processing performance and physical properties
US6966990B2 (en) * 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
RU2364400C2 (ru) * 2003-04-14 2009-08-20 Вектура Лтд Фармацевтические композиции
US20060147389A1 (en) * 2004-04-14 2006-07-06 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
GB0313604D0 (en) * 2003-06-12 2003-07-16 Britannia Pharmaceuticals Ltd Delivery device for powdered medicament
CA2538237A1 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20050191360A1 (en) * 2004-02-10 2005-09-01 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
PL2708225T3 (pl) * 2004-04-23 2019-07-31 Cydex Pharmaceuticals, Inc. Formulacja DPI zawierająca eter sulfoalkilowy cyklodekstryny
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
US20060134009A1 (en) * 2004-12-16 2006-06-22 Daniel Deaver Low dose corticosteroid powders for inhalation
CA2618710A1 (en) * 2005-08-11 2007-02-22 David Edwards Methods and compositions for dried cellular forms
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20070123449A1 (en) * 2005-11-01 2007-05-31 Advanced Inhalation Research, Inc. High load particles for inhalation having rapid release properties
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
GB0616299D0 (en) * 2006-08-16 2006-09-27 Cambridge Consultants Drug Capsules for dry power inhalers
EP2086617A4 (en) 2006-10-26 2013-11-20 Next Breath Llc INHALATION SYSTEM BASED ON PHOSPHOLIPIDS
US20080260852A1 (en) * 2007-01-23 2008-10-23 Ferro Pfanstiehl Laboratories, Inc. Supercritical fluid extraction produced by in-line homogenization
US7745566B2 (en) * 2007-01-23 2010-06-29 Ferro Corporation Methods for the purification of polymers
DK2425820T3 (en) 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
US20100215588A1 (en) * 2007-04-26 2010-08-26 Rami Skaliter Therapeutic delivery of inhibitory nucleic acid molecules to the respiratory system
WO2009052869A1 (en) * 2007-10-26 2009-04-30 Universita' Degli Studi Di Parma Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation
GB0721394D0 (en) * 2007-10-31 2007-12-12 Vectura Group Plc Compositions for trating parkinson's disease
CN102131827A (zh) * 2007-12-13 2011-07-20 葛兰素集团有限公司 用于肺部传递给药的组合物
MX2010006657A (es) * 2007-12-20 2010-10-05 Astrazeneca Ab Dispositivo y metodo para desagregar polvo 854.
CN101827626B (zh) 2008-06-13 2015-03-18 曼金德公司 干粉吸入器和用于药物输送的系统
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2421385T3 (es) * 2008-06-20 2013-09-02 Mannkind Corp Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
JP5841708B2 (ja) * 2008-07-01 2016-01-13 日東電工株式会社 表面被覆微粒子の医薬組成物
US20110253140A1 (en) * 2008-07-30 2011-10-20 Stc.Unm Formulations containing large-size carrier particles for dry powder inhalation aerosols
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
AU2009340790B2 (en) 2009-02-27 2016-03-24 Pari Gmbh Spezialisten Fur Effektive Inhalation Method for operating an aerosol inhalation device and aerosol inhalation device
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
KR102584844B1 (ko) 2009-06-12 2023-10-04 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
US20110171141A1 (en) * 2009-06-26 2011-07-14 Kellerman Donald J Administration of dihydroergotamine mesylate particles using a metered dose inhaler
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
EP2380618A1 (en) * 2010-04-26 2011-10-26 PARI Pharma GmbH Operating method for an aerosol delivery device and aerosol delivery device
CN102985125A (zh) 2010-06-21 2013-03-20 曼金德公司 干粉药物输送系统和方法
AU2011296343B2 (en) 2010-08-30 2015-12-10 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
MX2014004983A (es) 2011-10-24 2014-09-22 Mannkid Corp Metodos y composiciones para tratar dolor.
PT106094A (pt) 2012-01-13 2013-07-15 Hovione Farmaciencia S A Administração por inalação de formulações com dose elevada
KR102264177B1 (ko) 2012-07-12 2021-06-11 맨카인드 코포레이션 건조 분말 약물 전달 시스템 및 방법
RU2495682C1 (ru) * 2012-07-12 2013-10-20 Дарья Сергеевна Петренко Способ доставки лекарственного средства при лечении или профилактике табакокурения и/или заболеваний органов дыхания
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
KR102237007B1 (ko) * 2012-10-22 2021-04-06 키비타스 테라퓨틱스, 인코포레이티드. 레보도파 혈장 농도의 환자간 변산도의 감소
PT2908805T (pt) 2012-10-22 2021-09-10 Civitas Therapeutics Inc Formulações de levodopa para alívio rápido da doença de parkinson
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
KR102074543B1 (ko) * 2013-03-14 2020-02-06 노파르티스 아게 분무-블렌딩을 통한 분무-건조 제제의 탈무정형화
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
HK1218720A1 (zh) 2013-04-30 2017-03-10 欧缇托匹克公司 干粉制剂及使用方法
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
ES2922206T3 (es) 2014-02-20 2022-09-09 Otitopic Inc Formulaciones de polvo seco para la inhalación
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015163840A1 (en) 2014-04-21 2015-10-29 Civitas Therapeutics, Inc. Rapid relief of motor fluctuations in parkinson's disease
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3302423B1 (en) 2015-06-04 2022-05-25 Crititech, Inc. Particle production system and particle collection device
AU2016287582B2 (en) 2015-07-02 2020-03-12 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery
US20180303753A1 (en) * 2015-09-09 2018-10-25 Keith Try Ung Targeted delivery of spray-dried formulations to the lungs
BR112018069628A2 (pt) 2016-04-04 2019-02-12 Crititech, Inc. métodos para tratamento de tumor sólido
US10898494B2 (en) 2016-05-05 2021-01-26 Liquidia Technologies, Inc. Dry powder treprostinil for the treatment of pulmonary hypertension
KR20190126772A (ko) * 2017-03-07 2019-11-12 필립모리스 프로덕츠 에스.에이. 흡입 가능한 니코틴 제형, 및 이의 제조 및 사용 방법
EP3615145B1 (en) 2017-06-09 2024-05-15 Crititech, Inc. Compositions for use in the treatment of epithelial cysts by intracystic injection of antineoplastic particles
WO2018231908A1 (en) * 2017-06-14 2018-12-20 Crititech, Inc. Methods for treating lung disorders
KR20250057947A (ko) 2017-10-03 2025-04-29 크리티테크, 인크. 암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달
SI3935351T1 (sl) * 2019-03-08 2024-06-28 Chromaflo Technologies Europe B.V., Enota za doziranje trdnega barvila in stroj za barvanje, ki vsebuje to enoto
CN113318097A (zh) * 2021-04-29 2021-08-31 珠海瑞思普利医药科技有限公司 一种抗特发性肺纤维化的粉雾剂及制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
US5260306A (en) 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US5174988A (en) 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5304125A (en) 1990-10-05 1994-04-19 The University Of North Carolina Apparatus for administering solid particulate aerosols to the lungs
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
SE9203743D0 (sv) 1992-12-11 1992-12-11 Astra Ab Efficient use
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US5506203C1 (en) 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
GB9313650D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9313642D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
NZ281112A (en) * 1994-03-07 1998-04-27 Inhale Therapeutic Syst Powdered insulin delivered as an aerosol
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
US5641510A (en) 1994-07-01 1997-06-24 Genentech, Inc. Method for treating capsules used for drug storage
PL319600A1 (en) 1994-09-29 1997-08-18 Andaris Ltd Spray-dried microparticles as therapeutic carriers
US6165463A (en) 1997-10-16 2000-12-26 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
ES2237767T3 (es) 1995-04-14 2005-08-01 Nektar Therapeutics Composiciones farmaceuticas en polvo que tienen una dispersabilidad mejorada.
US6258341B1 (en) 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US6019968A (en) 1995-04-14 2000-02-01 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
GB9621825D0 (en) 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
DE69732306T2 (de) 1997-01-16 2006-01-12 Massachusetts Institute Of Technology, Cambridge Zubereitung von partikelhaltigen arzneimitteln zur inhalation
CN1169520C (zh) 1997-09-29 2004-10-06 耐科塔医药公司 多孔微粒及其使用方法
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20010007853A1 (en) * 1998-01-08 2001-07-12 Dimarchi Richard Dennis Method for administering monomeric insulin analogs
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
CA2336139C (en) 1998-06-24 2008-10-14 Advanced Inhalation Research, Inc. Large porous particles emitted from an inhaler
AU758351B2 (en) 1998-08-25 2003-03-20 Alkermes, Inc. Stable spray-dried protein formulations
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
DE60025019T2 (de) * 1999-10-29 2006-08-24 Nektar Therapeutics, San Carlos Trockenpulverzusammensetzungen mit verbesserter dispersivität
AU2001226029A1 (en) 2000-01-10 2001-07-24 Dura Pharmaceuticals, Inc. Pharmaceutical formulation and method for pulmonary and oral delivery
US6848197B2 (en) * 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
WO2002024158A3 (en) * 2000-09-19 2002-09-19 Advanced Inhalation Res Inc Pulmonary delivery in treating disorders of the central nervous system
US6979437B2 (en) 2000-09-19 2005-12-27 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
EP3061453A1 (en) * 2000-09-19 2016-08-31 Civitas Therapeutics, Inc. Pulmonary delivery of triptan
AU2002316574B2 (en) * 2002-03-15 2008-05-01 Brandeis University Central airway administration for systemic delivery of therapeutics
USRE43711E1 (en) 2002-03-20 2012-10-02 Civitas Therapeutics, Inc. Pulmonary delivery for levodopa
EP1531798A4 (en) * 2002-03-20 2010-11-03 Alkermes Inc PULMONARY LEVY OF LEVODOPA
US7879358B2 (en) 2002-03-20 2011-02-01 Alkermes, Inc. Pulmonary delivery for levodopa
WO2003079992A2 (en) 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Pulmonary delivery for levodopa
EP2494962A3 (en) * 2002-03-20 2013-01-16 Civitas Therapeutics, Inc. Pulmonary delivery for levodopa
EP2630954A1 (en) * 2002-03-20 2013-08-28 Civitas Therapeutics, Inc. Pulmonary delivery for levodopa
EP2893921A1 (en) * 2002-03-20 2015-07-15 Civitas Therapeutics, Inc. Method and apparatus for producing dry particles
EP1531794B1 (en) * 2002-06-28 2017-05-10 Civitas Therapeutics, Inc. Inhalable epinephrine
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
JP2006523632A (ja) * 2003-04-16 2006-10-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 放射標識された微粒子、その製造方法及びその使用
US8887715B2 (en) 2003-06-13 2014-11-18 Civitas Therapeutics, Inc. Low dose pharmaceutical powders for inhalation
WO2006033604A1 (en) * 2004-09-24 2006-03-30 Mederio Ag A metered medication dose
US9642800B2 (en) 2004-11-23 2017-05-09 Vectura Limited Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives
US9585834B2 (en) 2004-11-23 2017-03-07 Vectura Limited Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives
EA016072B1 (ru) * 2005-05-18 2012-01-30 Палметрикс Инк. Применение состава соли кальция для изменения биофизических свойств слизистой оболочки
US9119778B2 (en) 2009-03-26 2015-09-01 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
US9238005B2 (en) 2009-03-26 2016-01-19 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
US8758824B2 (en) 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
US9642798B2 (en) 2010-09-29 2017-05-09 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
US9744130B2 (en) 2010-09-29 2017-08-29 Pulmatrix Operating Company, Inc. Cationic dry powders
US10376465B2 (en) 2010-09-29 2019-08-13 Pulmatrix Operating Company, Inc. Monovalent metal cation dry powders for inhalation
US11173115B2 (en) 2010-09-29 2021-11-16 Pulmatrix Operating Company, Inc. Monovalent metal cation dry powders for inhalation
US10589039B2 (en) 2012-02-29 2020-03-17 Pulmatric Operating Company, Inc. Methods for producing respirable dry powders
US10806871B2 (en) 2012-02-29 2020-10-20 Pulmatrix Operating Company, Inc. Inhalable dry powders
US11235112B2 (en) 2012-02-29 2022-02-01 Pulmatrix Operating Company, Inc. Inhalable dry powders
US9539211B2 (en) 2012-11-09 2017-01-10 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US9737518B2 (en) 2013-04-01 2017-08-22 Pulmatrix Operating Company, Inc. Tiotropium dry powders
US9387169B2 (en) 2014-11-07 2016-07-12 Civitas Therapeutics, Inc. Rapamycin powders for pulmonary delivery

Also Published As

Publication number Publication date
PT1296663E (pt) 2007-06-22
JP2009019047A (ja) 2009-01-29
CA2412561A1 (en) 2001-12-20
US6858199B1 (en) 2005-02-22
PL360287A1 (en) 2004-09-06
JP2004503482A (ja) 2004-02-05
US7556798B2 (en) 2009-07-07
EP1296663B1 (en) 2007-03-21
CN100589796C (zh) 2010-02-17
NZ523254A (en) 2004-07-30
US20090068274A1 (en) 2009-03-12
KR100697479B1 (ko) 2007-03-20
WO2001095874A3 (en) 2003-01-16
MXPA02012023A (es) 2004-08-19
ATE357222T1 (de) 2007-04-15
US8628754B2 (en) 2014-01-14
EP1767196A2 (en) 2007-03-28
SI1296663T1 (sl) 2007-08-31
US20020035993A1 (en) 2002-03-28
DE60127407T2 (de) 2007-11-29
HK1051139A1 (en) 2003-07-25
KR20030063117A (ko) 2003-07-28
EP1767196A3 (en) 2009-02-25
US20120093893A1 (en) 2012-04-19
US20140178476A1 (en) 2014-06-26
NO20025873D0 (no) 2002-12-06
AU7536801A (en) 2001-12-24
ES2283417T3 (es) 2007-11-01
CA2412561C (en) 2009-05-12
IL153281A0 (en) 2003-07-06
AU2001275368B2 (en) 2005-10-20
NO20025873L (no) 2003-02-06
US6921528B2 (en) 2005-07-26
RU2275900C2 (ru) 2006-05-10
DK1296663T3 (da) 2007-07-30
DE60127407D1 (de) 2007-05-03
US20040076589A1 (en) 2004-04-22
CN1441670A (zh) 2003-09-10
EP1296663A2 (en) 2003-04-02

Similar Documents

Publication Publication Date Title
WO2001095874A2 (en) Highly efficient delivery of a large therapeutic mass aerosol
AU2001275368A1 (en) Highly efficient delivery of a large therapeutic mass aerosol
JP2004503482A5 (https=)
US5922354A (en) Methods and system for processing dispersible fine powders
Claus et al. How can we bring high drug doses to the lung?
AU724503B2 (en) Methods of dry powder inhalation
AU2014290438B2 (en) Heat-stable dry powder pharmaceutical compositions and methods
US6103270A (en) Methods and system for processing dispersible fine powders
Newman Dry powder inhalers for optimal drug delivery
RU2002134467A (ru) Способ высокоэффективной доставки аэрозоля с большой терапевтической массой
AU2003218307B8 (en) Pulmonary delivery for levodopa
NZ504711A (en) Soft-pellet drug and process for the preparation thereof
AU2003218306B2 (en) Method for administration of growth hormone via pulmonary delivery
JP2013237681A (ja) ドラッグ・デリバリー用の安定な金属イオン−脂質粉末状医薬組成物とその利用方法
EP1719505A3 (en) Pharmaceutical formulations for dry powder inhalers in the form of hard pellets
Staniforth Performance-modifying influences in dry powder inhalation systems
US7431916B2 (en) Administration of medicinal dry powders
EP1765291B1 (en) Enhanced medical product
AU2003260049B2 (en) Inhalation compositions with high drug ratios
Vanderbist et al. Optimization of a dry powder inhaler formulation of nacystelyn, a new mucoactive agent
CA2477592A1 (en) Powdery medicinal compositions for inhalation and process for producing the same
EP1110547A2 (en) Helium and neon as means delivering drug in inhaler
Clark et al. The application of pulmonary inhalation technology to drug discovery
US20250205153A1 (en) Inhalation composite and carrier based formulation combination
Mykhaylova Development of microparticle-nanoparticle powder mixtures for the use in dry powder inhalers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 153281

Country of ref document: IL

Ref document number: 2001942072

Country of ref document: EP

WWE Wipo information: entry into national phase

Country of ref document: MX

Ref document number: PA/a/2002/012023

WWE Wipo information: entry into national phase

Ref document number: 2412561

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2002 510053

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020027016748

Country of ref document: KR

Ref document number: 2001275368

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 523254

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2002134467

Country of ref document: RU

Kind code of ref document: A

Ref country code: RU

Ref document number: RU A

WWE Wipo information: entry into national phase

Ref document number: 018125336

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2001942072

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020027016748

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 523254

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 523254

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 2001275368

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2001942072

Country of ref document: EP